Skip to main content
Caplight Logo









Thermaquil Inc.

Thermaquil Inc.

Private
Philadelphia, PennsylvaniaHealthcare & Life Scienceshttps://www.thermaquil.com/

Last Round

Grant

Jan 4, 2021

Total Funding Raised

$4.55M

Company Overview

Thermaquil Inc. is a medical device company and manufacturer of a reversible device intended to block overactive nerves without relying on drugs, electrical stimulation, or causing nerve damage.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Clinical Trials

Business Model

B2G

Customer Profile

Government Contracts, Hardware Sales

AI Layer

Non-AI

Keywords

thermal neuromodulationreversible nerve blockdrug-free pain reliefpain management deviceneuromodulation deviceopioid alternativebioelectronic medicinechronic pain managementwearable medical devicenon-invasive medical devicemigraine treatmentDARPA contractorminimally invasive deviceelectroceuticalsbladder function restorationSBIR grant

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Thermaquil Inc. Comparables

Compare Thermaquil Inc. with similar companies based on industry and business-model similarity.

Thermaquil Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Neurolief
76%
electroCore
71%
Cefaly Technology
69%

Thermaquil Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJan 4, 2021

Thermaquil Inc. Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 4, 2021

    $1M grant awarded by the National Science Foundation.

Thermaquil Inc. Filings

Explore SEC and related filing metadata, where available.

Thermaquil Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Thermaquil Inc.'s valuation, stock price, and market status.

Is Thermaquil Inc. a public or private company?

Thermaquil Inc. is a private company.

What is the current stock price of Thermaquil Inc.?

Thermaquil Inc. is a private company with no public stock price. No recent secondary market data is available.

How much is Thermaquil Inc. worth (valuation)?

Valuation information for Thermaquil Inc. is not publicly available.

Can I buy Thermaquil Inc. stock?

Thermaquil Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Thermaquil Inc.'s last funding round?

Thermaquil Inc.'s most recent funding round was Grant on January 4, 2021.

Who are the main investors in Thermaquil Inc.?

Key investors in Thermaquil Inc. include U.S. Department of Health and Human Services, NIH RADx, Pitt Innovation Challenge, Defense Advanced Research Projects Agency, National Science Foundation.

Will Thermaquil Inc. IPO soon?

No public IPO plans have been announced for Thermaquil Inc..

How can I track Thermaquil Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Thermaquil Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersPhiladelphia, Pennsylvania
Employee Range2
Year Founded2017
Last FundingJan 4, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?